Stem cell treatment for interstitial lung disease
Part of Lungs & breathing clinical trials.
This study tests whether a single injection of stem cells from umbilical cord blood can improve lung function in people with interstitial lung disease. It might help reduce inflammation or repair damaged lung tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with interstitial lung disease.
- You have had a lung function test in the last 3 months showing your carbon monoxide diffusion is between 30% and 80% of normal, and your forced vital capacity is between 40% and 70% of normal.
- You are not currently using high-dose steroids or have unstable immunosuppressant treatment.
- You have not had significant lung infections, asthma, or oxygen therapy in the past month.
- You are not pregnant or breastfeeding, and have no history of cancer in the last 5 years (except for certain curable skin or cervical cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental treatment using tiny particles from human stem cells, given through a nebulizer (breathing mist). It aims to see if this treatment is safe and can help improve lung function in people with interstitial lung disease (lung scarring).
This trial tests whether a new treatment made from menstrual blood stem cells, given by injection, can help people with IPF, a condition that causes lung scarring and makes breathing harder. The study aims to see if the treatment can slow down the disease and improve lung function.
This trial tests a new treatment using stem cells from umbilical cords to help people with scleroderma-related lung disease. It aims to see if the treatment can slow down or improve lung scarring and breathing problems.
This study tests whether a patient's own lung stem cells can be used to repair damaged lungs in people with interstitial lung disease. It is an early-stage trial to see if the treatment is safe and may help improve breathing.
This trial tests whether adding umbilical cord stem cells to standard triple therapy can help people with Group E COPD. It aims to see if this approach improves lung function and quality of life.
This trial tests a treatment made from human umbilical cord stem cells for people with moderate ARDS. The goal is to see if it is safe and well-tolerated, and if it might help the lungs recover faster.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.